These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29454073)

  • 1. The accumulation of assembly intermediates of the mitochondrial complex I matrix arm is reduced by limiting glucose uptake in a neuronal-like model of MELAS syndrome.
    Geffroy G; Benyahia R; Frey S; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Inisan A; Renaud A; Chevrollier A; Henrion D; Bonneau D; Letournel F; Lenaers G; Reynier P; Procaccio V
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1596-1608. PubMed ID: 29454073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.
    Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
    Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells.
    Burgin HJ; Lopez Sanchez MIG; Smith CM; Trounce IA; McKenzie M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Cellular Bioenergetics Causes Mitochondrial Calcium Handling Defects in MT-ND5 Mutant Cybrids.
    McKenzie M; Duchen MR
    PLoS One; 2016; 11(4):e0154371. PubMed ID: 27110715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts.
    Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA
    FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?
    Liolitsa D; Rahman S; Benton S; Carr LJ; Hanna MG
    Ann Neurol; 2003 Jan; 53(1):128-32. PubMed ID: 12509858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids.
    Dunbar DR; Moonie PA; Zeviani M; Holt IJ
    Hum Mol Genet; 1996 Jan; 5(1):123-29. PubMed ID: 8789449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism derangements in adults with the MELAS m.3243A>G mutation.
    El-Hattab AW; Emrick LT; Hsu JW; Chanprasert S; Jahoor F; Scaglia F; Craigen WJ
    Mitochondrion; 2014 Sep; 18():63-9. PubMed ID: 25086207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-Induced Deregulation of Krebs Cycle in Mitochondrial Encephalopathy Lactic Acidosis Syndrome Stroke-Like Episodes (MELAS) Syndrome Is Alleviated by Ketone Body Exposure.
    Belal S; Goudenège D; Bocca C; Dumont F; Chao De La Barca JM; Desquiret-Dumas V; Gueguen N; Geffroy G; Benyahia R; Kane S; Khiati S; Bris C; Aranyi T; Stockholm D; Inisan A; Renaud A; Barth M; Simard G; Reynier P; Letournel F; Lenaers G; Bonneau D; Chevrollier A; Procaccio V
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myocardial infarction in a patient with MELAS syndrome: a possible link?
    Cosma J; Russo A; Schino S; Belli M; Mango R; Chiricolo G; Martuscelli E; Mariano EG
    Minerva Cardiol Angiol; 2023 Aug; 71(4):374-380. PubMed ID: 35767235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-mediated delivery of donor mitochondria improves mitochondrial function and cell viability in human cybrid cells with the MELAS A3243G mutation.
    Chang JC; Hoel F; Liu KH; Wei YH; Cheng FC; Kuo SJ; Tronstad KJ; Liu CS
    Sci Rep; 2017 Sep; 7(1):10710. PubMed ID: 28878349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.
    Hämäläinen RH; Manninen T; Koivumäki H; Kislin M; Otonkoski T; Suomalainen A
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3622-30. PubMed ID: 24003133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells.
    Jeong MH; Kim JH; Seo KS; Kwak TH; Park WJ
    Biochem Biophys Res Commun; 2014 Nov; 454(3):417-22. PubMed ID: 25451262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MELAS mutations 3946 and 3949 perturb the critical structure in a conserved loop of the ND1 subunit of mitochondrial complex I.
    Kervinen M; Hinttala R; Helander HM; Kurki S; Uusimaa J; Finel M; Majamaa K; Hassinen IE
    Hum Mol Genet; 2006 Sep; 15(17):2543-52. PubMed ID: 16849371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rapamycin on mitochondria and lysosomes in fibroblasts from patients with mtDNA mutations.
    Cheema NJ; Cameron JM; Hood DA
    Am J Physiol Cell Physiol; 2021 Jul; 321(1):C176-C186. PubMed ID: 34106788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).
    Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A
    Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.